PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of clopidogrel compared to placebo on
markers of inflammation in subjects with metabolic syndrome who are receiving background
therapy including low dose aspirin.